TRANXENE Side Effects

6931334-4 | Abortion Spontaneous
on Jun 21, 2010 Female patient from SWITZERLAND , 28 years of age, was treated with Tranxene (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Tranxene dosage: . During the same period patient was treated with AKINETON (4 Mg Milligram(s), Day 24, 2 Mg Milligram(s), Day 26, 4 Mg Milligram(s), Day 29) (View Akineton Review and Akineton Label ), CANNABIS (CANNABIS SATIVA) (View Cannabis (cannabis Sativa) Review and Cannabis (cannabis Sativa) Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), FLURAZEPAM HCL (View Flurazepam Hcl Review and Flurazepam Hcl Label ), MIANSERIN HYDROCHLORIDE (MIANSERIN HYDROCHLORIDE) (View Mianserin Hydrochloride (mianserin Hydrochloride) Review and Mianserin Hydrochloride (mianserin Hydrochloride) Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ).

6656380-X | Cardiac Failure, Fall, Hypokalaemia, Hyponatraemia, Pneumonia, Renal Failure Acute, Rhabdomyolysis
Patient was taking Tranxene (View Usage). Patient had the following side effects: cardiac failure, fall (What is fall?), hypokalaemia, hyponatraemia, pneumonia (What is pneumonia?), renal failure acute, rhabdomyolysis on Mar 15, 2010 from FRANCE Additional patient health information: Female patient , 88 years of age, was diagnosed with hypertension and. Tranxene dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), NEXIUM (View Nexium Review and Nexium Label ), CORDARONE (View Cordarone Review and Cordarone Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), TAHOR (View Tahor Review and Tahor Label ), LASIX (Daily Dose: 40 Milligram(s)) (View Lasix Review and Lasix Label ), COVERSYL 2 MG (Daily Dose: 2 Milligram(s)) (View Coversyl 2 Mg Review and Coversyl 2 Mg Label ). Patient was hospitalized.

6613430-4 | Aplasia, Coma, Malignant Neoplasm Progression, Metastatic Gastric Cancer, Overdose
Adverse event was reported on Feb 16, 2010 by a Male patient taking Tranxene (View Usage) (Dosage: Po) was diagnosed with gastric cancer and. Location: UNITED STATES , 42 years of age, After Tranxene was administered, patient had the following side effects: aplasia, coma, malignant neoplasm progression, metastatic gastric cancer, overdose. During the same period patient was treated with EPIRUBICIN HCL (NO PREF. NAME) (80 Mg/m2; Iv, 160 Mg) (View Epirubicin Hcl (no Pref. Name) Review and Epirubicin Hcl (no Pref. Name) Label ), CISPLATIN (95 Mg/m2; Iv, 190 Mg) (View Cisplatin Review and Cisplatin Label ), XELODA (3300 Mg; Po, 3000 Mg; Po) (View Xeloda Review and Xeloda Label ), HALDOL (View Haldol Review and Haldol Label ), ACTISKENAN (View Actiskenan Review and Actiskenan Label ), NEXIUM (View Nexium Review and Nexium Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ). Patient was hospitalized.

6598068-X | Depression, Overdose, Suicide Attempt
on Feb 08, 2010 Female patient from UNITED STATES , 38 years of age, was diagnosed with depression (What is depression?) and was treated with Tranxene (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), overdose, suicide attempt. Tranxene dosage: 150 Mg, 1x. During the same period patient was treated with MILNACIPRAN (1400 Mg, 1x, 50 Mg, Bid, Po) (View Milnacipran Review and Milnacipran Label ). Patient was hospitalized.


6344775-3 | Convulsion
on Aug 27, 2009 Female patient from UNITED STATES , 40 years of age, was treated with Tranxene (View Usage). Patient had the following side effects: convulsion. Tranxene dosage: Qd. During the same period patient was treated with SOMA (Qd) (View Soma Review and Soma Label ).

6322019-6 | Convulsion
Patient was taking Tranxene (View Usage). After Tranxene was administered, patient had the following side effects: convulsion on Mar 16, 2009 from UNITED STATES Additional patient health information: Male patient , 36 years of age, . Tranxene dosage: 3.75 Mg; Bid. During the same period patient was treated with REBIF (View Rebif Review and Rebif Label ), PROZAC (View Prozac Review and Prozac Label ), DILANTIN (View Dilantin Review and Dilantin Label ), KEPPRA (View Keppra Review and Keppra Label ). Patient was hospitalized.

6297778-1 | Mood Swings, Trichotillomania
Adverse event was reported on Aug 04, 2009 by a Female patient taking Tranxene (View Usage) (Dosage: ) . Location: UNITED STATES , 84 years of age, Patient experienced the following unwanted or unexpected effects: mood swings, trichotillomania.

5875963-8 | Blood Alcohol Increased, Coma, Incorrect Dose Administered, Leukocytosis, Pneumonia Aspiration, Pneumonia Staphylococcal, Rhonchi, Suicide Attempt
on Aug 22, 2008 Female patient from FRANCE , 26 years of age, was diagnosed with suicide attempt and was treated with Tranxene (View Usage). Patient had the following side effects: blood alcohol increased, coma, incorrect dose administered, leukocytosis, pneumonia aspiration, pneumonia staphylococcal, rhonchi, suicide attempt. Tranxene dosage: 10 Mg; ;op. During the same period patient was treated with ANAFRANIL (75 Mg; ;op) (View Anafranil Review and Anafranil Label ), TERCIAN (CYAMEMAZINE) (25 Mg; ;op) (View Tercian (cyamemazine) Review and Tercian (cyamemazine) Label ), SEROPLEX (NO PREF. NAME) (;op) (View Seroplex (no Pref. Name) Review and Seroplex (no Pref. Name) Label ). Patient was hospitalized.

5859105-0 | Dermatitis Bullous
on Aug 01, 2008 Female patient from UNITED STATES , 41 years of age, was diagnosed with anxiety (What is anxiety?), depression (What is depression?), schizophrenia and was treated with Tranxene (View Usage). After Tranxene was administered, patient had the following side effects: dermatitis bullous. Tranxene dosage: ; Po. During the same period patient was treated with ESCITALOPRAM (; Po) (View Escitalopram Review and Escitalopram Label ), ZYPREXA (; Po) (View Zyprexa Review and Zyprexa Label ), ATARAX (; Po) (View Atarax Review and Atarax Label ). Patient was hospitalized.

5841926-1 | Convulsion
Patient was taking Tranxene (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion on Aug 11, 2008 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 150.0 lb, was diagnosed with epilepsy (What is epilepsy?) and. Tranxene dosage: 7.5 Mg 2x Daily Po. During the same period patient was treated with MYLAN (View Mylan Review and Mylan Label ).

5628956-X | Completed Suicide
Adverse event was reported on Jan 31, 2008 by a Female patient taking Tranxene (View Usage) (Dosage: Po) . Location: UNITED STATES , 46 years of age, Patient had the following side effects: completed suicide. During the same period patient was treated with GLIPIZIDE (Po) (View Glipizide Review and Glipizide Label ), BENZODIAZEPINE DERIVATIVES (Po) (View Benzodiazepine Derivatives Review and Benzodiazepine Derivatives Label ).

5314552-0 | Asthenia, Dermatitis Allergic, Disorientation, Dyssomnia, Headache, Hypersensitivity, Nausea, Presyncope, Rash
on Apr 14, 2007 Female patient from UNITED STATES , 80 years of age, was diagnosed with anxiety (What is anxiety?) and was treated with Tranxene (View Usage). After Tranxene was administered, patient had the following side effects: asthenia, dermatitis allergic, disorientation, dyssomnia, headache (What is headache?), hypersensitivity, nausea (What is nausea?), presyncope, rash (What is rash?). Tranxene dosage: 3.75 Mg; Qd; Po. During the same period patient was treated with LEXAPRO (10 Mg; Po) (View Lexapro Review and Lexapro Label ), PAXIL (View Paxil Review and Paxil Label ). Patient was hospitalized.

5312757-6 | Anomaly Of External Ear Congenital, Dysmorphism, Oesophageal Atresia
on Apr 23, 2007 Male patient from , weighting 6.39 lb, was treated with Tranxene (View Usage). Patient experienced the following unwanted or unexpected effects: anomaly of external ear congenital, dysmorphism, oesophageal atresia. Tranxene dosage: . During the same period patient was treated with CHLORPROMAZINE HCL (View Chlorpromazine Hcl Review and Chlorpromazine Hcl Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), TROPATEPINE (View Tropatepine Review and Tropatepine Label ), BUPRENORPHINE HCL (View Buprenorphine Hcl Review and Buprenorphine Hcl Label ).

5257143-2 | Suicide Attempt
Patient was taking Tranxene (View Usage). Patient had the following side effects: suicide attempt on Feb 15, 2007 from UNITED STATES Additional patient health information: Female patient , 36 years of age, . Tranxene dosage: Po. During the same period patient was treated with LUNESTA (Po) (View Lunesta Review and Lunesta Label ), MOTRIN (View Motrin Review and Motrin Label ).

5132953-0 | Abdominal Pain, Hepatic Necrosis
Adverse event was reported on Oct 11, 2006 by a Female patient taking Tranxene (View Usage) (Dosage: ) . Location: FRANCE , 28 years of age, After Tranxene was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), hepatic necrosis. During the same period patient was treated with ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), GESTODENE AND ETHINYL ESTRADIOL (Once : Gestodene+ethinylestradiol:10.08 Mg+2.52 Mg) (View Gestodene And Ethinyl Estradiol Review and Gestodene And Ethinyl Estradiol Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), DEROXAT (View Deroxat Review and Deroxat Label ). Patient was hospitalized.

5093299-2 | Acute Respiratory Distress Syndrome, Depressed Level Of Consciousness, Hypotension
on Aug 16, 2006 Male patient from FRANCE , 54 years of age, was diagnosed with abnormal behaviour and was treated with Tranxene (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, depressed level of consciousness, hypotension. Tranxene dosage: See Image. During the same period patient was treated with DEPAKOTE (500 Mg; Qid; Po) (View Depakote Review and Depakote Label ), TIAPRIDE (TIAPRIDE) (See Image) (View Tiapride (tiapride) Review and Tiapride (tiapride) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NULYTELY (View Nulytely Review and Nulytely Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), VALPROMIDE (View Valpromide Review and Valpromide Label ). Patient was hospitalized.

5092929-9 | Ecchymosis, Thrombocytopenia
on Aug 17, 2006 Female patient from FRANCE , 55 years of age, was treated with Tranxene (View Usage). Patient had the following side effects: ecchymosis, thrombocytopenia. Tranxene dosage: 50 Mg; Qd; Po. During the same period patient was treated with VENLAFAXINE HCL (75 Mg; Po) (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), CYAMEMAZINE (CYAMEMAZINE) (100 Mg; Qd; Po) (View Cyamemazine (cyamemazine) Review and Cyamemazine (cyamemazine) Label ), DEPAKOTE (2 Gm; Qd; Po) (View Depakote Review and Depakote Label ), HEPARIN FRACTION, SODIUM SALT (View Heparin-fraction, Sodium Salt Review and Heparin-fraction, Sodium Salt Label ). Patient was hospitalized.

5085993-4 | Abnormal Behaviour, Depression, Febrile Infection, Femur Fracture, Hyperhidrosis, Hypotension, Mental Disorder, Pancreatic Necrosis, Pancreatitis Acute
Patient was taking Tranxene (View Usage). After Tranxene was administered, patient had the following side effects: abnormal behaviour, depression (What is depression?), febrile infection, femur fracture, hyperhidrosis, hypotension, mental disorder, pancreatic necrosis, pancreatitis acute on Aug 01, 2006 from FRANCE Additional patient health information: Male patient , 35 years of age, was diagnosed with epilepsy (What is epilepsy?), febrile infection, depression (What is depression?), abnormal behaviour, mental disorder and. Tranxene dosage: . During the same period patient was treated with DEPAKENE (500 Mg; Qd; Po) (View Depakene Review and Depakene Label ), METRONIDAZOLE (500 Mg; Tid; Po) (View Metronidazole Review and Metronidazole Label ), ROXITHROMYCIN (ROXITHROMYCIN) (150 Mg/ Bid; Po) (View Roxithromycin (roxithromycin) Review and Roxithromycin (roxithromycin) Label ), HEPARIN (5000 Iu; Qd; Sc) (View Heparin Review and Heparin Label ), SERTRALINE (50 Mg; Bid; Po) (View Sertraline Review and Sertraline Label ), OLANZAPINE (20 Mg; Qd; Po) (View Olanzapine Review and Olanzapine Label ), BACLOFEN (View Baclofen Review and Baclofen Label ). Patient was hospitalized.

5050370-9 | Abnormal Behaviour, Depression, Mental Disorder, Pancreatitis
Adverse event was reported on Jun 26, 2006 by a Male patient taking Tranxene (View Usage) (Dosage: ) was diagnosed with epilepsy (What is epilepsy?), depression (What is depression?), mental disorder and. Location: FRANCE , 35 years of age, Patient experienced the following unwanted or unexpected effects: abnormal behaviour, depression (What is depression?), mental disorder, pancreatitis. During the same period patient was treated with DEPAKENE (500 Mg; Qd; Po) (View Depakene Review and Depakene Label ), METRONIDAZOLE (500 Mg; Tid; Po) (View Metronidazole Review and Metronidazole Label ), ROXITHROMYCIN (ROXITHROMYCIN) (150 Mg; Bid; Po) (View Roxithromycin (roxithromycin) Review and Roxithromycin (roxithromycin) Label ), HEPARIN (5000 Iu; Qd; Sc) (View Heparin Review and Heparin Label ), SERTRALINE (50 Mg; Bid; Po) (View Sertraline Review and Sertraline Label ), OLANZAPINE (20 Mg; Qd; Po) (View Olanzapine Review and Olanzapine Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), POTASSIUM CHLORIDE (600 Mg; Qd; Po) (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

4851863-7 | Visual Acuity Reduced, Visual Field Defect
on Nov 29, 2005 Female patient from UNITED STATES , 32 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Tranxene (View Usage). Patient had the following side effects: visual acuity reduced, visual field defect. Tranxene dosage: 50 Mg; Qd; Po. During the same period patient was treated with INIPOMP (PANTOPRAZOLE) (Po) (View Inipomp (pantoprazole) Review and Inipomp (pantoprazole) Label ), METHOTREXATE (2.5 Mg; Qw; Po) (View Methotrexate Review and Methotrexate Label ), PAROXETINE HCL (Po) (View Paroxetine Hcl Review and Paroxetine Hcl Label ).

4822499-9 | Visual Acuity Reduced, Visual Field Defect
on Oct 27, 2005 Female patient from FRANCE , 32 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Tranxene (View Usage). After Tranxene was administered, patient had the following side effects: visual acuity reduced, visual field defect. Tranxene dosage: 50 Mg;qd;po. During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), METHOTREXATE (2.5 Mg;qw;po) (View Methotrexate Review and Methotrexate Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ).

4787089-5 | Visual Acuity Reduced, Visual Field Defect
Patient was taking Tranxene (View Usage). Patient experienced the following unwanted or unexpected effects: visual acuity reduced, visual field defect on Sep 20, 2005 from FRANCE Additional patient health information: Female patient , 32 years of age, . Tranxene dosage: 50.00 Mg; Qd; Po. During the same period patient was treated with PANTOPRAZOLE SODIUM (Po) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), METHOTREXATE (2.5 Mg;qw; Po) (View Methotrexate Review and Methotrexate Label ), PAROXETINE HYDROCHLORIDE (Po) (View Paroxetine Hydrochloride Review and Paroxetine Hydrochloride Label ).

4747760-8 | Crying, Rhinorrhoea
Adverse event was reported on Aug 08, 2005 by a Female patient taking Tranxene (View Usage) (Dosage: 50 Mg;qd;im) was diagnosed with insomnia and. Location: FRANCE , 36 years of age, Patient had the following side effects: crying, rhinorrhoea. During the same period patient was treated with NUCTALON (ESTAZOLAM) (2.0 Mg;qd;po) (View Nuctalon (estazolam) Review and Nuctalon (estazolam) Label ), CYAMEMAZINE (CYAMEMAZINE) (25.0 Mg;qd;po) (View Cyamemazine (cyamemazine) Review and Cyamemazine (cyamemazine) Label ), MIANSERIN HYDROCHLORIDE (MIANSERIN HYDROCHLORIDE) (45.0 Mg;qd;po) (View Mianserin Hydrochloride (mianserin Hydrochloride) Review and Mianserin Hydrochloride (mianserin Hydrochloride) Label ), OXAZEPAM (75.0 Mg;qd;po) (View Oxazepam Review and Oxazepam Label ), PAROXETINE HCL (20.0 Mg;qd;po) (View Paroxetine Hcl Review and Paroxetine Hcl Label ), ACETAMINOPHEN W/ PROPOXYPHENE HCL (View Acetaminophen W/ Propoxyphene Hcl Review and Acetaminophen W/ Propoxyphene Hcl Label ).

4705692-5 | Activated Partial Thromboplastin Time Prolonged, Coagulopathy, Meniscus Operation, Suicide Attempt
on Jun 23, 2005 Female patient from , 35 years of age, was diagnosed with suicide attempt, thrombosis prophylaxis and was treated with Tranxene (View Usage). After Tranxene was administered, patient had the following side effects: activated partial thromboplastin time prolonged, coagulopathy, meniscus operation, suicide attempt. Tranxene dosage: 650 Mg; 1x. During the same period patient was treated with DEPAKOTE (5000 Mg; 1x; Po) (View Depakote Review and Depakote Label ), MEPRONIZINE (MEPROBAMATE/ACEPROMETAZINE) (4100 Mg; 1x; Po) (View Mepronizine (meprobamate/aceprometazine) Review and Mepronizine (meprobamate/aceprometazine) Label ), HEPARIN FRACTION SODIUM SALT (54000 Iu; 1x; Sc) (View Heparin-fraction Sodium Salt Review and Heparin-fraction Sodium Salt Label ), HEPARIN FRACTION SODIUM SALT (54000 Iu; 1x; Sc) (View Heparin-fraction Sodium Salt Review and Heparin-fraction Sodium Salt Label ). Patient was hospitalized.

4698985-1 | Condition Aggravated, Convulsion
on Jun 22, 2005 Male patient from , child 12 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Tranxene (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, convulsion. Tranxene dosage: 1 Tab Bid.